BioNTech and Moderna: A tale of two mRNA developers
Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...
BioNTech, OncoC4 Phase 3 study put on partial hold by FDA
BioNTech (BNTX) and OncoC4 have had a partial clinical hold placed by the FDA on a Phase 3 study for BNT316/ONC-392 in the ...
BioNTech shares slip as FDA places partial clinical hold on lung cancer study
BioNTech (NASDAQ: BNTX) shares fell Friday after the company said it had been informed by partner OncoC4 that FDA placed ...
What to Expect From Pfizer's Q3 2024 Earnings Report
For fiscal 2024, analysts expect PFE to report an EPS of $2.66, up 44.6% from $1.84 in fiscal 2023 . Shares of PFE have ...
Truist Financial Corp Has $1.27 Million Stock Position in BioNTech SE (NASDAQ:BNTX)
Truist Financial Corp lowered its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 4.1% in the second quarter ...
Morgan Stanley Sticks to Its Buy Rating for BioNTech SE (BNTX)
In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a ...
Investing4d
GSK sues Moderna for US patent infringement over COVID, RSV vaccines
GSK filed a related lawsuit against Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) in the same court in April over their COVID-19 vaccine. The new litigation seeks unspecified monetary damages.
US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns
Novavax's protein-based COVID vaccine is the biotech's only commercial product. The shot has failed to make a significant ...
ca.investing.com on MSN2d
Novavax shares sink as US FDA puts trial of combo COVID-flu vaccine on hold
Shares in Novavax (NASDAQ:NVAX) slumped in premarket US trading on Wednesday after the US Food and Drug Administration placed a trial of its experimental COVID-19 and influenza vaccine combination on ...